Login Register
English
0

Cart

$ 0

A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma.(KTB1100-3.400)

Date:2025-07-25 Views:4